Colin Garner
Impact in
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
- Antibiotics Pharmacokinetics and Efficacy
- Pharmaceutical Science top 10%
- Drug Solubulity and Delivery Systems
Papers in
-
- DNA Repair Mechanisms 2
-
- Pharmacological Effects and Toxicity Studies 2
- Co-authors
- Graham Lappin (3 shared papers)Yoko Shishikura (3 shared papers)Malcolm Rowland (2 shared papers)B. Oosterhuis (2 shared papers)Roeline Jochemsen (2 shared papers)Ole J. Bjerrum (2 shared papers)Richard Weaver (2 shared papers)Brian Houston (1 shared paper)
- Journals
- European Journal of Pharmaceutical Sciences (3 papers)Analytical Biochemistry (1 paper)Clinical Cancer Research (1 paper)Carcinogenesis (1 paper)British Journal of Clinical Pharmacology (1 paper)
- Partner nations
- United KingdomPolandNetherlands
In The Last Decade
Colin Garner
14 papers receiving 308 citations
Peers
Comparison fields: 5 of 78
- Pharmacology 76
- Pharmaceutical Science 31
- Chemical Health and Safety 3
- Molecular Medicine 17
- Small Animals 25
Countries citing papers authored by Colin Garner
This map shows the geographic impact of Colin Garner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Colin Garner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Colin Garner more than expected).
Fields of papers citing papers by Colin Garner
This network shows the impact of papers produced by Colin Garner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Colin Garner. The network helps show where Colin Garner may publish in the future.
Co-authors
The 25 scholars most cited alongside Colin Garner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 93 | |
| 2 | 2011 | 46 | |
| 3 | 2013 | 28 | |
| 4 | 2000 | 26 | |
| 5 | 2007 | 22 | |
| 6 | 2008 | 20 | |
| 7 | 2015 | 19 | |
| 8 | 2013 | 15 | |
| 9 | 1988 | 15 | |
| 10 | 2016 | 13 | |
| 11 | 1992 | 11 | |
| 12 | 2009 | 8 | |
| 13 | 2021 | 2 | |
| 14 | 2021 | 2 | |
| 15 | 2004 | 1 |
About Colin Garner
Colin Garner is a scholar working on Molecular Biology, Pediatrics, Perinatology and Child Health, Ecology, Pharmacology and Spectroscopy, having authored 15 papers that have together received 321 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (2 papers), Isotope Analysis in Ecology (2 papers), DNA Repair Mechanisms (2 papers), Analytical chemistry methods development (2 papers), Analytical Chemistry and Chromatography (2 papers), Pharmacological Effects and Toxicity Studies (2 papers), Pesticide Residue Analysis and Safety (2 papers) and Chronic Myeloid Leukemia Treatments (1 paper). The work is most often cited by research in Pharmacology (76 citations), Pharmaceutical Science (31 citations), Chemical Health and Safety (3 citations), Molecular Medicine (17 citations) and Small Animals (25 citations). Colin Garner has collaborated with scholars based in United Kingdom, Poland and Netherlands. Frequent co-authors include Graham Lappin, Yoko Shishikura, Malcolm Rowland, B. Oosterhuis, Roeline Jochemsen, Ole J. Bjerrum, Richard Weaver, Brian Houston, Barry Hafkin and Nachum Kaplan. Their work appears in journals such as European Journal of Pharmaceutical Sciences, Analytical Biochemistry, Clinical Cancer Research, Carcinogenesis and British Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.